These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 31394020

  • 21. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
    Nagai S, Chau LC, Kitajima T, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Moonka D.
    Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
    [Abstract] [Full Text] [Related]

  • 22. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW.
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [Abstract] [Full Text] [Related]

  • 23. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, Wood NL, Gentry SE, Kwong AJ.
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [Abstract] [Full Text] [Related]

  • 24. Exception Policy Change Increased the Simultaneous Kidney-Liver Transplant Probability of Polycystic Disease in the Centers With High Median MELD at Transplantation.
    Miyake K, Kim DY, Chau LC, Trudeau S, Kitajima T, Wickramaratne N, Shimada S, Nassar A, Yoshida A, Abouljoud MS, Nagai S.
    Transplantation; 2024 Jul 01; 108(7):1632-1640. PubMed ID: 38548699
    [Abstract] [Full Text] [Related]

  • 25. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen HR, Biggins SW.
    Liver Transpl; 2015 Nov 01; 21(11):1365-73. PubMed ID: 25865434
    [Abstract] [Full Text] [Related]

  • 26. The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.
    Salvalaggio P, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Einstein (Sao Paulo); 2012 Nov 01; 10(3):278-85. PubMed ID: 23386004
    [Abstract] [Full Text] [Related]

  • 27. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
    Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ.
    Hepatol Int; 2016 Sep 01; 10(5):838-46. PubMed ID: 27221700
    [Abstract] [Full Text] [Related]

  • 28. [Predictors of mortality among liver transplant candidates].
    Erez D, Ben Ari Z, Michowitz R, Mor E.
    Harefuah; 2011 Jan 01; 150(1):16-20, 70, 69. PubMed ID: 21449150
    [Abstract] [Full Text] [Related]

  • 29. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35.
    Nekrasov V, Matsuoka L, Rauf M, Kaur N, Cao S, Groshen S, Alexopoulos SP.
    Am J Transplant; 2016 Oct 01; 16(10):2912-2924. PubMed ID: 27063579
    [Abstract] [Full Text] [Related]

  • 30. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.
    Swenson SM, Roberts JP, Rhee S, Perito ER.
    Am J Transplant; 2019 Dec 01; 19(12):3308-3318. PubMed ID: 31370108
    [Abstract] [Full Text] [Related]

  • 31. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.
    Sundaram V, Jalan R, Wu T, Volk ML, Asrani SK, Klein AS, Wong RJ.
    Gastroenterology; 2019 Apr 01; 156(5):1381-1391.e3. PubMed ID: 30576643
    [Abstract] [Full Text] [Related]

  • 32. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index.
    Biggins SW, Gralla J, Dodge JL, Bambha KM, Tong S, Barón AE, Inadomi J, Terrault N, Rosen HR.
    Am J Transplant; 2014 Nov 01; 14(11):2588-94. PubMed ID: 25243648
    [Abstract] [Full Text] [Related]

  • 33. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S, Chau LC, Schilke RE, Safwan M, Rizzari M, Collins K, Yoshida A, Abouljoud MS, Moonka D.
    Gastroenterology; 2018 Nov 01; 155(5):1451-1462.e3. PubMed ID: 30056096
    [Abstract] [Full Text] [Related]

  • 34. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA, Polak WG, Porte RJ, van Hoek B, van den Berg AP, Metselaar HJ, IJzermans JNM.
    J Hepatol; 2018 Apr 01; 68(4):707-714. PubMed ID: 29221886
    [Abstract] [Full Text] [Related]

  • 35. Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.
    Braun HJ, Perito ER, Dodge JL, Rhee S, Roberts JP.
    Am J Transplant; 2016 Nov 01; 16(11):3181-3191. PubMed ID: 27214757
    [Abstract] [Full Text] [Related]

  • 36. Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.
    Kim WR, Mannalithara A, Kwo PY, Bonham CA, Kwong A.
    Hepatology; 2023 Mar 01; 77(3):851-861. PubMed ID: 36052665
    [Abstract] [Full Text] [Related]

  • 37. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct 01; 44(8):2283-5. PubMed ID: 23026574
    [Abstract] [Full Text] [Related]

  • 38. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group.
    J Hepatol; 2014 Feb 01; 60(2):290-7. PubMed ID: 24161408
    [Abstract] [Full Text] [Related]

  • 39. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N, Kelly B, Soltys K, Squires JE, Vockley J, Shellmer DA, Strauss K, McKiernan P, Ganoza A, Sindhi R, Bond G, Mazariegos G, Khanna A.
    Clin Transplant; 2019 Nov 01; 33(11):e13721. PubMed ID: 31556146
    [Abstract] [Full Text] [Related]

  • 40. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
    Genda T, Ichida T, Sakisaka S, Sata M, Tanaka E, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y.
    J Gastroenterol; 2014 Feb 01; 49(2):324-31. PubMed ID: 23478939
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.